1. Home
  2. ARTW vs AIMD Comparison

ARTW vs AIMD Comparison

Compare ARTW & AIMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Art's-Way Manufacturing Co. Inc.

ARTW

Art's-Way Manufacturing Co. Inc.

HOLD

Current Price

$2.70

Market Cap

13.4M

Sector

Industrials

ML Signal

HOLD

AIMD

Ainos Inc.

HOLD

Current Price

$2.80

Market Cap

13.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARTW
AIMD
Founded
1956
1984
Country
United States
United States
Employees
N/A
41
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.4M
13.1M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
ARTW
AIMD
Price
$2.70
$2.80
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
11.8K
824.9K
Earning Date
04-13-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
233.33
N/A
EPS
0.04
N/A
Revenue
$22,975,408.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$66.00
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.69
$0.45
52 Week High
$4.69
$4.50

Technical Indicators

Market Signals
Indicator
ARTW
AIMD
Relative Strength Index (RSI) 53.99 69.70
Support Level $2.07 $1.51
Resistance Level $2.96 $3.98
Average True Range (ATR) 0.10 0.35
MACD -0.01 0.12
Stochastic Oscillator 48.21 57.18

Price Performance

Historical Comparison
ARTW
AIMD

About ARTW Art's-Way Manufacturing Co. Inc.

Art's-Way Manufacturing Co Inc is a manufacturer of agricultural equipment. It has two reportable segments: Agricultural Products and Modular Buildings. The Agricultural Products segment fabricates and sells farming products as well as related equipment and replacement parts for these products in the United States and world wide. Its Modular Buildings segment manufactures and installs modular buildings for animal containment and various laboratory uses. It derives revenues from the Agricultural Products segment.

About AIMD Ainos Inc.

Ainos Inc is a dual-platform company advancing artificial intelligence based smelltech technologies and immune therapeutics. Its primary strategic focus is the commercialization of its proprietary scent digitization platform, AI Nose, while the company also continue to develop therapeutic assets based on its low-dose oral interferon program, VELDONA. Its core technology platform, AI Nose, is an AI-based electronic olfaction system that integrates gas sensor arrays with proprietary artificial intelligence models, which it refers to as a smell language model (SLM), to digitize scent and volatile organic compound (VOC) signals into Smell ID, a machine-readable data format.

Share on Social Networks: